نتائج البحث

The Role of FLT3-ITD Mutation, PI3K/AKT Pathway, and Leukemia Stem Cells in D3A7 Induction therapy - the Outcomes of Adult Indonesian Patients with Acute Myeloid Leukemia.

• Authors : Arwanih EY; Doctoral Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Subjects: fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/genetics ; fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/metabolism ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

• Source: Acta medica academica [Acta Med Acad] 2024 Aug; Vol. 53 (2), pp. 165-175.Publisher: Akademija nauka i umjetnosti Bosne i Hercegovine Country of Publication: Bosnia and Herzegovina NLM ID: 101587903 Publication Model: Print Cited

تفاصيل العنوان

Favorable outcome of PML-RARα short isoform and FLT3-ITD mutation in a patient with several adverse prognostic markers: A case report.

• Authors : Bafail MA; Department of Pathology and Clinical Laboratory Medicine, Administration, Hematology, Molecular Pathology and Cytogenetics Sections King Fahad Medical City Riyadh Saudi Arabia.; AlTahan R

• Source: Clinical case reports [Clin Case Rep] 2023 Jul 06; Vol. 11 (7), pp. e07637. Date of Electronic Publication: 2023 Jul 06 (Print Publication: 2023).Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904

تفاصيل العنوان

Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.

• Authors : Saburi M; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.; Sakata M

• Source: Case reports in hematology [Case Rep Hematol] 2023 Aug 23; Vol. 2023, pp. 7164742. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).Publisher: Wiley Country of Publication: United States NLM ID: 101576456 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6560

تفاصيل العنوان

Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.

• Authors : Ayala R; Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, 28041 Madrid, Spain.; Carreño-Tarragona G

• Source: Cancers [Cancers (Basel)] 2022 Nov 24; Vol. 14 (23). Date of Electronic Publication: 2022 Nov 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

تفاصيل العنوان

Upregulation of FHL1 , SPNS3 , and MPZL2 predicts poor prognosis in pediatric acute myeloid leukemia patients with FLT3-ITD mutation.

• Authors : Eshibona N; SAMRC Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.; Giwa A

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/diagnosis ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Nuclear Proteins*/Nuclear Proteins*/Nuclear Proteins*/genetics

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Aug; Vol. 63 (8), pp. 1897-1906. Date of Electronic Publication: 2022 Mar 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation.

• Authors : Xu D; Department of Hematology, Nanfang Hospital, Southern Medical University, No. 1838 Guangzhou Avenue North, Guangzhou, 510515, China.; Chen Y

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

• Source: Journal of translational medicine [J Transl Med] 2022 Jul 06; Vol. 20 (1), pp. 300. Date of Electronic Publication: 2022 Jul 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

• Authors : Zhang LS; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.

• Source: OncoTargets and therapy [Onco Targets Ther] 2022 Feb 18; Vol. 15, pp. 159-164. Date of Electronic Publication: 2022 Feb 18 (Print Publication: 2022).Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.

• Authors : Al Hamed R; Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA.; Labopin M

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy

• Source: Cancer medicine [Cancer Med] 2022 Feb; Vol. 11 (4), pp. 1068-1080. Date of Electronic Publication: 2022 Jan 20.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

The prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia.

• Authors : Nie L; Zhengzhou University, Zhengzhou, China.; Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China.

Subjects: Leukemia, Myeloid, Acute* ; Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/diagnosis ; Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/genetics

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2020 Oct; Vol. 61 (10), pp. 2482-2487. Date of Electronic Publication: 2020 May 30.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients.

• Authors : Rinaldi I; Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.; Louisa M

• Source: OncoTargets and therapy [Onco Targets Ther] 2021 Feb 26; Vol. 14, pp. 1479-1486. Date of Electronic Publication: 2021 Feb 26 (Print Publication: 2021).Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان